Patents by Inventor Alan Pease

Alan Pease has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240121162
    Abstract: A simulation environment (e.g., multi-player game) hosted by a provider network may implement componentized entities to reduce the amount of resource usage for a simulation (e.g., by reducing the amount of input/state data transmitted through the use of dynamically changing input structures). A user may add or remove any number of components to an entity that is simulated at the local client device. When inputs are received for one or more components, values for predictive states are locally determined for each component. An input packet is generated and sent to the provider network, which includes the inputs as well as data that is based on the values for the locally predicted states (e.g., a fingerprint or other unique ID). If necessary, a correction packet may be generated at the provider network and sent back to the client.
    Type: Application
    Filed: December 7, 2023
    Publication date: April 11, 2024
    Applicant: Amazon Technologies, Inc.
    Inventors: Karl Berg, Joseph Pease, Neema Teymory, Alan Krause
  • Publication number: 20240091373
    Abstract: Disclosed herein are surfactant free lyophilized formulations of antibody-drug conjugates (ADCs), such as anti-tissue factor ADCs, and reconstituted formulations, processes and uses thereof. The formulations are particularly suitable for an anti-TF ADC based on an auristatin derivative or other similarly hydrophobic drug. Typically, the excipients of the formulations comprise or consist of histidine, sucrose, trehalose, mannitol and glycine.
    Type: Application
    Filed: December 13, 2022
    Publication date: March 21, 2024
    Inventors: Jesper VALBJØRN, Xiaona JING, Kelly Ann ROBY, Timothy Warren PAUL, Gregory Allan SACHA, Nathan Alan PEASE, Bodil WILLUMSEN
  • Patent number: 11918792
    Abstract: The present disclosure relates to a dose detection system for use with a medication delivery device in which a dose setting member rotates relative to an actuator during dose delivery. The dose detection system includes a module which is removably attached to the medication delivery device. The module includes a rotation sensor attached to the actuator during dose delivery. A sensed element is attached to the dose setting member and includes surface features detectable by the rotation sensor. The rotation sensor comprises a following member including a contact portion resting against and spring-biased in the direction of the surface features. The contact surface is positioned to move over the surface features during rotation of the sensed element, and the rotation sensor is responsive to the movement of the contact portion over the surface features to detect the rotation of the dose setting member.
    Type: Grant
    Filed: December 13, 2022
    Date of Patent: March 5, 2024
    Inventors: Matthew Thomas Antonelli, William Churchill Taliaferro Burke, Roy Howard Byerly, Christopher Robert McCaslin, Ethan Edward Pease, Kenneth Alan Ritsher
  • Publication number: 20200246477
    Abstract: Disclosed herein are surfactant free lyophilized formulations of antibody-drug conjugates (ADCs), such as anti-tissue factor ADCs, and reconstituted formulations, processes and uses thereof. The formulations are particularly suitable for an anti-TF ADC based on an auristatin derivative or other similarly hydrophobic drug. Typically, the excipients of the formulations comprise or consist of histidine, sucrose, trehalose, mannitol and glycine.
    Type: Application
    Filed: January 14, 2020
    Publication date: August 6, 2020
    Inventors: Jesper VALBJØRN, Xiaona JING, Kelly Ann ROBY, Timothy Warren PAUL, Gregory Allan SACHA, Nathan Alan PEASE, Bodil WILLUMSEN
  • Patent number: 10617764
    Abstract: Disclosed herein are surfactant free lyophilized formulations of antibody-drug conjugates (ADCs), such as anti-tissue factor ADCs, and reconstituted formulations, processes and uses thereof. The formulations are particularly suitable for an anti-TF ADC based on an auristatin derivative or other similarly hydrophobic drug. Typically, the excipients of the formulations comprise or consist of histidine, sucrose, trehalose, mannitol and glycine.
    Type: Grant
    Filed: November 21, 2014
    Date of Patent: April 14, 2020
    Assignee: GENMAB A/S
    Inventors: Jesper Valbjørn, Xiaona Jing, Kelly Ann Roby, Timothy Warren Paul, Gregory Allan Sacha, Nathan Alan Pease, Bodil Willumsen
  • Publication number: 20160279258
    Abstract: Disclosed herein are surfactant free lyophilized formulations of antibody-drug conjugates (ADCs), such as anti-tissue factor ADCs, and reconstituted formulations, processes and uses thereof. The formulations are particularly suitable for an anti-TF ADC based on an auristatin derivative or other similarly hydrophobic drug. Typically, the excipients of the formulations comprise or consist of histidine, sucrose, trehalose, mannitol and glycine.
    Type: Application
    Filed: November 21, 2014
    Publication date: September 29, 2016
    Inventors: Jesper VALBJØRN, Xiaona JING, Kelly Ann ROBY, Timothy Warren PAUL, Gregory Allan SACHA, Nathan Alan PEASE, Bodil WILLUMSEN
  • Patent number: 4172155
    Abstract: A method of surfacing mill guide rolls 1 in which a metallic powder (6) is deposited on to the surface of the rotatable roll by flame, arc or plasma spraying, fusion welded and then shaped and compacted while in a plastic condition by a roll former 7 rotatable and engageable with the guide roll whereby to impart thereto a surface in conformity with the profile of the former.
    Type: Grant
    Filed: May 23, 1978
    Date of Patent: October 23, 1979
    Assignee: British Steel Corporation
    Inventor: Alan Pease